Tumor homing peptides can be considered as other promising chemical targeting agents, for example, Lyp-1, which has the p32 protein (HABP1 or C1QR protein) as its receptor, can be conjugated to various drug delivery systems to increase their targeting abilities. Here, C1QBP is linked to neoplasm.